Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders

Abstract

Fibroblast growth factor (FGF) 21 is a member of the endocrine FGF subfamily. FGF21 expression is induced under different disease conditions, such as type 2 diabetes, obesity, chronic kidney diseases, and cardiovascular diseases, and it has a broad spectrum of functions in regulating various metabolic parameters. Many different approaches have been pursued… (More)
DOI: 10.3389/fendo.2015.00168

Topics

  • Presentations referencing similar topics